Shanghai Pharmaceutical Group Co., Ltd

Industry

  • Pharmaceuticals
    • OTC, Consumer
    • Vaccines
    • Specialty Pharmaceuticals
  • Distributors
  • Medical Devices
  • Services

Other Names/Subsidiaries

  • Beijing Kyuan Pharmaceutical
  • Cardinal Health China
  • CITIC Pharmaceutical
  • Shanghai Jiaolian Drug Research and Development
  • Shanghai No. 1 Biochemical & Pharmaceutical
  • Shanghai Pharmaceutical Group
  • Shanghai Sine Tianping Pharmaceutical
  • SPH Chromo
  • Techpool Bio-pharma
See more in Biomedtracker

Latest on Shanghai Pharmaceutical Group Co., Ltd

Scrip

UCB Divests Products, Manufacturing Site In China To CBC, Mubadala

 
• By Joseph Haas

Who: UCB/CBC Group/Mubadala What: UCB is divesting some mature neurology and allergy products in China, as well as a manufacturing site in that country, to CBC and Mubadala. Why: UCB said the tra

In Vivo

Innovative Drugs: China Gains Deals, But Financing Amounts Drop

 
• By Mainbayar Badarch

The Chinese innovative drug market was valued at CNY709.7bn ($97.7bn) in 2023 and is expected to hit CNY753.4bn in 2024 due to the influence of medical insurance adjustments and increased R&D expendit

Scrip

Pfizer Divests Select China Prevenar 13 Rights, Staff As Domestic Firms Gain Traction

 
• By Brian Yang

Pfizer Inc. is divesting most rights to its Prevenar 13 vaccine (13-valent, pneumococcal polysaccharide conjugate) in China to a domestic company, in the latest localization move involving vaccines f

Pink Sheet

China Approves Two More Home-Grown COVID-19 Antivirals

 
• By Dexter Jie Yan

China’s drug regulator has conditionally approved Shanghai Junshi Biosciences Co., Ltd. ’s deuremidevir (JT001/VV116) and Simcere Pharmaceutical Group ’s combination antiviral simnotrelvir plus rito